SALIVARY GLAND CANCER STAGE IV

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting SALIVARY GLAND CANCER STAGE IV:

# Drug Count
0 ALLOPURINOL 6
1 FLUOXETINE 6
2 FLUOXETINE HYDROCHLORIDE 6
3 FUROSEMIDE 6
4 METHYLDOPA 6
5 ETOPOSIDE 5
6 ROPINIROLE 5
7 BISOPROLOL FUMARATE 4
8 DICLOFENAC 4
9 DICLOFENAC SODIUM 4
See all common drugs associated with SALIVARY GLAND CANCER STAGE IV

SALIVARY GLAND CANCER STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METHYLDOPA 6 0.0012
1 ROPINIROLE 5 0.0003
2 SORAFENIB 4 0.0002
3 LOPERAMIDE HYDROCHLORIDE 4 0.0001
4 ETOPOSIDE 5 0.0001
5 FLUOXETINE HYDROCHLORIDE 6 0.0000
6 ALLOPURINOL 6 0.0000
7 BISOPROLOL FUMARATE 4 0.0000
8 DICLOFENAC SODIUM 4 0.0000
9 CARBOPLATIN 3 0.0000
See all drugs enriched for association with SALIVARY GLAND CANCER STAGE IV

SALIVARY GLAND CANCER STAGE IV is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nonergot Dopamine Agonist [EPC] 5 0.0003
1 Topoisomerase Inhibitor [EPC] 5 0.0001
2 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
3 Loop Diuretic [EPC] 6 0.0000
4 Platinum-based Drug [EPC] 3 0.0000
5 Kinase Inhibitor [EPC] 4 0.0000
6 Proton Pump Inhibitor [EPC] 4 0.0000
7 Azole Antifungal [EPC] 1 0.0000
8 Interferon beta [EPC] 1 0.0000
9 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
See all drug classes enriched for association with SALIVARY GLAND CANCER STAGE IV